Efficacity of Cognitive Remediation Treatment Compared to a Controlled Group in Young Patient With Anorexia Nervosa
NCT ID: NCT02400541
Last Updated: 2020-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2015-03-31
2019-12-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Remediation Therapy in Anorexia Nervosa
NCT01772394
Evaluation of the Effectiveness of Add-on Hometreatment to Family Based Therapy in Adolescent Anorexia Nervosa.
NCT05418075
Contribution of a Virtual Reality Program in the Treatment of Dysmorphophobia for Adolescent Female With Anorexia Nervosa
NCT03426930
Exploration of the Mechanisms of Vulnerability of Anorexia Nervosa at an Early Age : Study of the Cognitive Treatment of Food Stimuli and Body Image
NCT04037215
A Relapse Prevention Program for Reducing Relapse and Fear of Food in People With Anorexia Nervosa
NCT00627341
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Those factors are:
Weight, perfectionism and food symptomatology, temperament, therapeutic alliance and change motivation, clinical evolution of anorexia nervosa, self esteem, executive functions, neuropsychological performance (flexibility and central coherence).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive remediation therapy
10 sessions of the cognitive remediation therapy program conducted during five weeks
Cognitive remediation therapy
Our scheme comprises 10 biweekly sessions ( 5 in group and 5 single) . Each session last about 45 minutes.
Individual sessions will be held with the patient and a therapist trained in the CRT; group sessions will be led by two therapists trained in CRT and regroup the maximum 5 patients.
relaxation therapy
10 relaxation sessions during 5 weeks
relaxation therapy
Our scheme comprises 10 biweekly sessions. Each session last about 45 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive remediation therapy
Our scheme comprises 10 biweekly sessions ( 5 in group and 5 single) . Each session last about 45 minutes.
Individual sessions will be held with the patient and a therapist trained in the CRT; group sessions will be led by two therapists trained in CRT and regroup the maximum 5 patients.
relaxation therapy
Our scheme comprises 10 biweekly sessions. Each session last about 45 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* DSM IV criteria of restrictive anorexia nervosa (AN- R), but not requiring amenorrhea or DSM V
* Accepting and their parents to participate in the study ( signed consents )
* Topics
* Female supported for AN- R
* Aged 8 to 16 years
* Fluent French
* Inpatients or outpatients suffering of restrictive anorexia nervosa
* Treatments
* Supports standard load ( family psychotherapy , dietary management , medical monitoring )
* In case of anxiety or depression , patients may receive additional psychotropic prescription which should be mentioned in the record
* Treatments previously followed by patients and treatments for other conditions should be described
Exclusion Criteria
* Mental Retardation
* Schizophrenia
* Organic brain disorder ( encephalitis , degenerative brain tumor , cerebral neuro- degenerative disease , multiple sclerosis , amyotrophic lateral sclerosis, epilepsy )
* Metabolic Pathology interfere with feeding or its regulation
* Trouble consumption current substance
* Severe somatic pathology , progressive or likely to be life -threatening
* Topics The subjects are not mastering the French language will not be considered
* Subjects or parents do not have sufficient capacity for understanding instructions and consent
* No affiliation in social security ( beneficiary or legal )
8 Years
16 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Asch Muriel, PHD
Role: PRINCIPAL_INVESTIGATOR
-Hôpital Robert Debré, Service de psychiatrie de l'enfant et de l'adolescent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asch
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P130905
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.